Condition: Pancreatoduodenectomy · Pain Management · Opioid Analgesia · Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy
The goal of this clinical trial is to determine whether continuous nefopam administration, as part of a multimodal analgesia strategy, reduces opioid consumption and improves patient satisfaction after pancreatoduodenectomy. The main questions are: Does nefopam administration reduce opioid consumption after pancreatoduodenectomy? Does nefopam administration reduce postoperative pain levels after pancreatoduodenectomy? Researchers will compare two other analgesic strategies, namely continuous lidocaine infusion and epidural analgesia, to assess whether they lead to better outcomes. Participants will complete the QoR-15 questionnaire and report their pain levels at predefined time points before and after surgery.
This description comes directly from the study's public registry record.
Andrei O Mitre · +40724275556 · andrei.otto.mitre@elearn.umfcluj.ro
Always discuss trial participation with your own doctor first.
| Prof. O. Fodor Regional Institute of Gastroenterology and Hepatology | Cluj-Napoca, Cluj, Romania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07423650